Tu carrera profesionalRelaciones con InversoresCOVID-19
  1. Home
  2. Clinical Fields
  3. Cardiología
  4. Atención cardiovascular sostenible
  5. Clinical Talks

Clinical Talks

Prostate cancer radiopharmaceutical therapy: Beyond the basic | Vendor Workshop at RSNA 2023

 2023-11-28

Joseph R. Osborne, MD, PhD, Chief, Molecular Imaging and Therapeutics, Professor of Radiology, Director of the Radiology Health Equity Lab at New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New. York, USA.

PSMA PET: Technical and clinical case review | Vendor Workshop at RSNA 2023

 2023-11-26

Nicholas Feinberg, MD, Assistant Professor of Radiology, University of Chicago Medicine, Chicago, Illinois, USA.

Timing is of the essence: Unlocking the potential of PET/CT imaging with time of flight

 2023-09-28

Dr. Ian Armstrong, Nuclear Medicine Consultant Physicist, Manchester University NHS Foundation Trust, United Kingdom.

The potential Impact of Total Body PET to Whole Person Research and Network Medicine

 2023-09-09

Discover how Prof. Dr. Marcus Hacker envisions the potential of Total Body PET for whole person research and its effects on network medicine. 

EANM 2023

Symbia Pro.specta: Putting the "Pro" in SPECT/CT imaging

 2023-08-25
Alex Torres, CNMT, (ARRT)(N)(CT); Natasha Befrui, BS, CNMT, (ARRT)(N)(CT); Nuclear Medicine Technologists, Department of Radiology, Houston Methodist Hospital, Houston, Texas, USA.

Empowering precision oncology: Expanding access to next-generation theranostics

 2023-08-10
Joseph R. Osborne, MD, PhD; Chief, Division of Molecular Imaging and Therapeutics, Professor of Radiology, Weill Cornell Medicine, New York, New York.

Clinical experience of routine SPECT/CT reading after migrating from Symbia.net to syngo.via

 2023-05-09
Iain Duncan, MD, Garran Medical Imaging, Canberra, Australia

Artificial intelligence in breast imaging: chances, challenges, and concerns

 2023-03-01

The expert panel with Prof. Dr. Sylvia Heywang-Köbrunner, Dr. Solveig Hofvind and Dr. Ritse Mann shed light on the role of Artificial Intelligence in the clinical routine of breast cancer screening and diagnostics. They discuss the chances, challenges, and concerns that put the use of AI in mammography and tomosynthesis to the test. (ECR, March, 2023)

The latest on contrast media examinations in breast imaging - Interview

 2023-03-01

Dr. Ritse Mann, Dr. Panagiotis Kapetas, Dr. Paola Clauser and Prof. Dr. Isabelle Thomassin-Naggara address current clinical and scientific results of contrast media-based imaging in breast diagnostics in the fields of ultrasound, mammography, and magnetic resonance imaging. (ECR, March, 2023)

The latest on contrast media examinations in breast imaging - Interview

 2023-03-01

Dr. Ritse Mann gives an answer on the current European recommendations for contrast media examinations and the associated political issues. (ECR, March, 2023)

Artificial intelligence in breast imaging: chances, challenges, and concerns - Interview

 2023-03-01

Dr. Ritse Mann summarizes the chances, challenges and concerns related to Artificial Intelligence in breast imaging, screening and diagnostics. (ECR, March, 2023)

Artificial intelligence in mammography 

 2022-11-28

Prof. Dr. Rachel Brem (George Washington University, Washington, USA) and Dr. Brian S. Englander (Pennsylvania Hospital, Philadelphia, USA) talk about the impact of artificial intelligence (AI) on cancer detection and compare AI to radiologists’ interpretations of 2D and 3D mammograms. (RSNA, Nov. 2022)

The migration to wide-angle breast tomosynthesis  

 2022-11-28

Dr. Brandie Fagin (Rush University Medical Center, Chicago, USA) guides through cases to become familiar with the value of 50° wide-angle breast tomosynthesis images and the ease-of-use of the reading solutions on MAMMOVISTA B.smart. (RSNA, Nov. 2022)

Future of PET and how it is diversifying

 2022-10-15

Prof. Juhani Knuuti, MD, PhD, University of Turku and Tukru University Hospital, Turku, FInland

siemens healthineers How did the pandemic harm breast screening programs and what should a return strategy look like?

How did the pandemic harm breast screening programs and what should a return strategy look like?

 2022-08-29
In this keynote talk Prof. Dr. Federica Pediconi (Sapienza University of Rome, Italy) reviews the literature regarding the effect of the pandemic on screening programs and breast cancer mortality. She analyzes how the pandemic has modified the approach to patient care, current restart strategies, and possible directions for the future. (ECR, July 2022)